Skubitz A
ORCID: 0000-0003-4672-3450
· 5 papers in corpus
2026
BackgroundEarlier detection is strongly associated with increased survival for women with ovarian cancer. Unfortunately, current screening strategies, employing serial serum or ultrasound assessments, lack adequate sensitivity and specifici…
2025
PurposeTo evaluate exemestane, an aromatase inhibitor, as a preventive intervention for endometrial cancer.Experimental designThis is a multicenter, single-arm, "window of opportunity" pilot study of exemestane (25 mg daily for 21-42 days) …
2011
Claudin 4 is a cellular adhesion molecule that is frequently overexpressed in ovarian cancer and other epithelial cancers. In this study, we sought to determine whether the expression of claudin 4 is associated with outcome in ovarian cance…
2010
BackgroundNew biomarkers that replace or are used in conjunction with the current ovarian cancer diagnostic antigen, CA125, are needed for detection of ovarian cancer in the presurgical setting, as well as for detection of disease recurrenc…
2010
Early detection of ovarian cancer is difficult owing to the lack of specific and sensitive tests available. Previously, we found expression of nectin 4 to be increased in ovarian cancer compared with normal ovaries. Reverse transcriptase-po…